Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

NPA pleased doctors will get CPCS incentive

The National Pharmacy Association says it's pleased that GPs are being incentivised to engage with the Community Pharmacist Consultation Service (CPCS), which is convenient for patients, frees up GP appointments and makes good use of community pharmacists’ skills to handle minor illnesses.

Health secretary Sajid Javid has announced a new £250 million winter access fund for general practice to increase capacity and encourage GPs to provide more face-to-face consultations.


Talking to Jeremy Vine on BBC Radio 2 on Thursday (October 14), NPA chair Andrew Lane said: “Everyone in the NHS – pharmacists, nurses, hospital staff and GPs - have worked incredibly hard over the past two years and stepped up to keep people well during the pandemic.

“The way people have accessed primary care has changed, with more people using the phone or going online, but very often people do want to talk a healthcare professional in person.

“Nearly two million people visit a pharmacy every day, usually without an appointment, to get highly convenient, face-to-face advice and treatment.”

Community pharmacists can do even more

He told the programme that community pharmacists could do even more to take pressure off GPs in the future if the NHS invests in services that incorporate independent prescribing.

Lane added: “This is all happening at a time when funding for pharmacies is falling and hundreds of pharmacies have closed over the last few years.  It’s good if money has been found for general practice, but let’s not forget the rest of the NHS team who are working just as hard on the frontline of the health service.”

More For You

Chemotherapy-free leukaemia treatment

The trial found that a combination of two cancer drugs, ibrutinib and venetoclax, could perform better than chemotherapy among patients with chronic lymphocytic leukaemia.

iStock

Chemotherapy-free leukaemia treatment shows promise during trial

In a breakthrough in leukaemia research, scientists in the UK have tested a chemotherapy-free approach, involving a combination of targeted drugs, which may offer better outcomes.

The new treatment could radically change the way chronic lymphocytic leukaemia (CLL), the most common form of leukaemia in adults, is treated.

Keep ReadingShow less
Locum pharmacists in the UK work in a difficult environment, and many are dissatisfied with their jobs.

Locum pharmacists in the UK work in a difficult environment, and many are dissatisfied with their jobs.

iStock

Locums should stand up for their interests, say 'no' to unfair terms: PDA

The Pharmacists' Defence Association (PDA) has advised locum pharmacists to be vigilant about their interests and negotiate directly with their businesses, avoid working with digital platforms driven by algorithms, and be aware of regressive contract terms.

The not-for-profit organisation issued such an advisory following its survey of 1,300 UK locum pharmacists, which showed that they work in a difficult environment and that most are dissatisfied with their jobs.

Keep ReadingShow less
Wales ranked worst for second-trimester abortion access in the UK

Each year about 175 women travel from Wales to England for care

Wales ranked worst for second-trimester abortion access in the UK

A leading healthcare charity has revealed that Wales is the worst part of the United Kingdom for allowing surgical abortions for women.

Surgical abortion is the process removing pregnancy from the womb by inducing local anaesthesia, conscious sedation or general anaesthesia.

Keep ReadingShow less
The fund offers £150 per eligible child - for up to three children per household.

The fund offers £150 per eligible child - for up to three children per household.

Charity reopens funding to ease back to school financial pressures for community pharmacists

Community pharmacists struggling with the costs of their children going back to school can apply for funding from The Leverhulme Trade Charities Trust (LTCT)

The Trust is providing up to £100,000 of support to those working in a community pharmacy or are a registered pharmacist or pharmacy technician

Keep ReadingShow less
Germany's BioNTech to buy CureVac to boost cancer research

Both biotech companies have been working for years in the area of mRNA vaccines and treatments

Germany's BioNTech to buy CureVac to boost cancer research

Germany's BioNTech is buying domestic rival CureVac for $1.25 billion, bringing together two pharmaceutical firms specialised in mRNA technology with the goal of advancing cancer treatments.

BioNTech, which developed the first coronavirus vaccine to be approved in the West along with US pharmaceutical giant Pfizer, said the acquisition would "bring together complementary capabilities and leverage technologies".

Keep ReadingShow less